Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Supplementary Data (download XLS Data for Supplementary Fig
Patients typically start at 0.20.5 mg, advancing 0.250.5 mg increments weekly or bi-weekly until reaching maintenance doses of 2.03.0 mg
Advantages include its established safety history and FDA clearance for use in adolescents as young as 12 years old
(After a legal challenge by compounders, that tirzepatide shortage resolution was then postponed until December 19.) Theres no prescribed timeline for the FDA to resolve a shortage once it reports a product is available
Blood glucose variations towards week's end typically result from lifestyle factors such as diet, activity, stress, or sleep rather than diminishing drug effect
US$ 22.18
US$ 25.57
US$ 20.56
US$ 26.64
US$ 23.27
US$ 20.17
